Financials data is unavailable for this security.
View more
Year on year Unicocell Biomed Co Ltd grew revenues 70.79% from 14.40m to 24.59m while net income improved from a loss of 91.16m to a smaller loss of 84.11m.
Gross margin | 66.09% |
---|---|
Net profit margin | -570.24% |
Operating margin | -629.34% |
Return on assets | -14.06% |
---|---|
Return on equity | -15.95% |
Return on investment | -14.42% |
More ▼
Cash flow in TWDView more
In 2023, cash reserves at Unicocell Biomed Co Ltd fell by 33.74m. Cash Flow from Financing totalled 339.01m or 1,378.69% of revenues. In addition the company used 65.55m for operations while cash used for investing totalled 307.20m.
Cash flow per share | -1.39 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 12.32 |
---|---|
Tangible book value per share | 12.32 |
More ▼
Balance sheet in TWDView more
Current ratio | 29.82 |
---|---|
Quick ratio | 29.58 |
Total debt/total equity | 0.0991 |
---|---|
Total debt/total capital | 0.0902 |
More ▼